摘要 |
Specific Compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein m, X, R, R2, R3, R, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease. |
申请人 |
F. HOFFMANN-LA ROCHE AG;BAKER-GLENN, CHARLES;BURDICK, DANIEL JON;CHAMBERS, MARK;CHAN, BRYAN K.;CHEN, HUIFEN;ESTRADA, ANTHONY;GUNZNER-TOSTE, JANET;SHORE, DANIEL;SWEENEY, ZACHARY;WANG, SHUMEI;ZHAO, GUILING |
发明人 |
BAKER-GLENN, CHARLES;BURDICK, DANIEL JON;CHAMBERS, MARK;CHAN, BRYAN K.;CHEN, HUIFEN;ESTRADA, ANTHONY;GUNZNER-TOSTE, JANET;SHORE, DANIEL;SWEENEY, ZACHARY;WANG, SHUMEI;ZHAO, GUILING |